Researchers at University of Tsukuba report that patients with congenital heart disease (CHD) who were more physically active ...

Recent advances in cardiovascular pharmacology have spotlighted that biological sex profoundly influences not only drug responses, but also the real-world ...

The development of an embryo is one of the most fundamental processes in biology. Early in this process, it is determined ...

Stanford's James Zou targets $1B valuation for AI physiology startup backed by Nature-published research and FDA-cleared cardiac AI ...

Kyowa Kirin Co., Ltd. (TSE: 4151, “Kyowa Kirin”) and Kura Oncology, Inc. (Nasdaq: KURA, “Kura”) today announced the first patient has been dosed in a Japanese Phase 2 registrational clinical trial ...

A Florida IVF clinic is being sold amidst a lawsuit after a woman gave birth to a baby that was not genetically hers. The couple who gave birth to the child filed a lawsuit after genetic testing ...

15,000 shares were sold for a transaction value of approximately $928,950 at a weighted average price of around $61.93 per share on Feb. 5, 2026. The sale accounted for 22.9% of Andrew Callos' direct ...

Heart disease remains the leading cause of death worldwide, yet progress in understanding and treating cardiac disorders is limited by the shortcomings of existing experimental models. Traditional ...

Cardiogenic shock is characterized by depression of cardiac function that leads to low blood pressure, coronary ischemia, and further decreased cardiac contractility resulting in tissue hypoxemia. The ...

Future Cardia, a medical device company, announced an expanded collaboration with remote cardiac monitoring company, Artella Solutions. Future Cardia is developing an implantable cardiac monitoring ...

A pregnant woman in Kentucky who filed a lawsuit demanding the right to an abortion has learned her embryo no longer has cardiac activity, her attorneys said Tuesday. Her attorneys didn't immediately ...